725MO Phase I Trial of the DLL3/CD3 IgG-like T Cell Engager BI 764532 in Patients (pts) with DLL3-positive (+) Tumours: Focus on Neuroendocrine Carcinomas
Annals of oncology(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Annals of oncology(2023)